← Open Payments lookup

TAMI ORTON: Open Payments

NPI 1407452873 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,486 in 146 payments from 17 companies in 2025. Trend: 2023 $1,171 · 2024 $3,051 · 2025 $2,486

Food & beverage: $2,486
CompanyPaymentsAmount
ABBVIE INC.39$529
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$409
E.R. Squibb & Sons, L.L.C.16$252
Axsome Therapeutics, Inc.8$249
Teva Pharmaceuticals USA, Inc.13$234
JAZZ PHARMACEUTICALS INC.10$174
Otsuka America Pharmaceutical, Inc.12$165
Janssen Pharmaceuticals, Inc8$141
HARMONY BIOSCIENCES LLC3$79
Neurocrine BioSciences, Inc.3$53

Products named: VRAYLAR, CAPLYTA, COBENFY, Auvelity, XYWAV, UZEDY, REXULTI, INVEGA SUSTENNA.

Industry payments across NE — which companies pay providers there.